Condition
Atrial Fibrillation (AF) clinical trials and research
As of November 12, 2026, Find a Trial lists 137 Atrial Fibrillation (AF) clinical trials that are recruiting, at sites in 54 countries (most in China (30), United States (24), Germany (14)). 3 were first registered in the last 30 days. By phase: Phase 3 (6), Phase 2 (5), Phase 4 (4), Phase 2/3 (1). The most active sponsors are Beijing Anzhen Hospital (10), Samsung Medical Center (4), Charles University, Czech Republic (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 137Clinical trials
- 3New in 30 days
- 54Countries
Newest Atrial Fibrillation (AF) clinical trials
All recruiting trials (137)
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
-
AI-based cardiac analysis using 12-lead and 1-lead ECG
A clinician-facing pilot test to see if SmartECG-EF helps evaluate heart function using both 12-lead and single-lead ECGs in adults with heart conditions.
-
Long-term half-dose apixaban versus aspirin after Watchman implantation
This trial tests whether continuing a half-dose blood thinner (apixaban) is better than aspirin after Watchman device implantation in people with atrial fibrillation.
-
Factors Linked to Slow Heart Rate After Pulsed Field Ablation for Atrial Fibrillation
This study looks for factors that might cause bradycardia during the hospital stay after AF ablation using pulsed field technology.
-
Finerenone after catheter ablation to see if it reduces AF recurrence
This pilot study tests whether adding finerenone after first-time AF ablation can lower the chance of AF coming back over 12 months in adults.
-
Budiodarone for paroxysmal AF: a dose-escalation safety and feasibility study
This study tests whether budiodarone is safe and helps control paroxysmal atrial fibrillation in about 100 adults over 6 months, using dose adjustments guided by AF monitoring.
-
Detecting Atrial Fibrillation with Smartphone Camera Heart Rate Signals
This study tests whether a smartphone camera-based PPG algorithm can detect atrial fibrillation in adults who are being evaluated for AF, by comparing its output to a standard 12-lead ECG.
-
Blood lipid and ceramide profiles in atrial fibrillation
This study tests whether blood lipid and ceramide patterns differ between people with atrial fibrillation and those with other heart diseases.
-
Edoxaban vs. Apixaban in AF with CAD: Net Benefit
This trial tests whether edoxaban-based therapy provides a similar or better overall benefit than apixaban-based therapy for stroke prevention and major bleeding in adults with atrial fibrillation and coronary artery disease.
-
Photoplethysmography-based algorithm to detect atrial fibrillation in heart failure patients
A wearable-based, AI-powered test using PPG signals to see if a patient with heart failure has atrial fibrillation.
-
Caffeine and Heart-Rate Control in Permanent Atrial Fibrillation
This trial tests whether continuing moderate coffee intake affects 24-hour heart-rate control in people with permanent atrial fibrillation who normally use caffeine.
-
Mild Sedation with Remimazolam and Fentanyl During Pulsed-Field Ablation for Atrial Fibrillation
This study tests whether a light, monitored sedation with remimazolam and fentanyl during REM (pulsed-field) ablation for AF can replace deeper anesthesia in adults.
-
Very high-power short-duration vs standard low-power radiofrequency ablation for atrial fibrillation
This trial tests whether very high-power short-duration ablation (90 W) is as safe and more effective than conventional low-power ablation (35-45 W) for treating atrial fibrillation.
-
Personalized AF ablation: anatomy-based vs Emphasize map-guided substrate ablation
We’re testing two catheter ablation approaches for persistent atrial fibrillation to see which one leads to fewer or shorter episodes of abnormal heart rhythms over a year.
-
Cardiac ablation for endurance athletes with atrial fibrillation
This study tests whether catheter ablation can help endurance athletes with atrial fibrillation and how it might affect their performance.
-
Pulsed field ablation for AF: isolated Superior Vena Cava plus Pulmonary Vein isolation
This study tests a pulsed field ablation approach to treat atrial fibrillation by isolating the pulmonary veins and the superior vena cava in adults who have not responded well to standard medications.
-
Risk score for predicting embolism in AF patients on DOACs
This study checks a risk score to see if it can predict embolism in people with atrial fibrillation who are taking direct oral anticoagulants.
-
BodyGuardian Monitoring for Recurrence of Atrial Fibrillation
This study tests wearing the BodyGuardian monitor after AF ablation to see if it helps track and understand recurrence in patients who had the FARAPULSE PFA system.
-
BDNF Levels and Atrial Cardiomyopathy in People Having AF Ablation
This study tests whether circulating BDNF levels are linked to atrial cardiomyopathy in adults having their first ablation for persistent atrial fibrillation.
-
Predicting Atrial Fibrillation with a Genetic Risk Score
Researchers test whether a polygenic risk score can help flag people likely to have undiagnosed atrial fibrillation, alongside at-home and clinic heart monitoring.
-
Personalized Atrial Fibrillation Ablation Using Unipolar QS-Potential Mapping
In people with atrial fibrillation who are having catheter ablation, this study tests whether guiding the procedure with unipolar QS-potential mapping can improve outcomes compared with standard pulmonary vein isolation.
-
Preventing stroke and systemic embolism in adults with atrial fibrillation using REGN7508 compared with apixaban
This trial tests REGN7508 in adults with atrial fibrillation to see if it can prevent stroke and blood clots better or as well as apixaban.
-
Remapping Before/During LAAO: Testing Durable Pulsed Field Ablation for Atrial Fibrillation
We’re testing whether a pulsed field ablation done during a planned left atrial appendage occlusion procedure stays effective over time in adults with atrial fibrillation.
-
Intensive lifestyle changes after AF ablation in people who are overweight
The study tests whether an intensive diet and exercise program after AF ablation helps overweight patients do better than standard follow-up care.
-
What happens to the tricuspid valve in atrial fibrillation patients without strong valve leakage
This study looks at how the tricuspid valve changes over a year in people with atrial fibrillation who don’t have significant valve leakage, using 3D heart imaging.
-
Screening for heart failure in older adults with atrial fibrillation in rural China
We’re testing whether HF screening in 65–80 year olds with AF in rural China can help identify heart failure early and track progression over time.
-
Optimal shock energy for electrical cardioversion of atrial fibrillation
This study tests whether starting with a higher initial shock energy for electrical cardioversion helps restore normal rhythm in people with atrial fibrillation.
-
Early rhythm control in atrial fibrillation with tricuspid regurgitation
This study tests whether starting rhythm control early in people with atrial fibrillation and tricuspid regurgitation can improve outcomes compared with usual care.
-
Pulsed Field Ablation Outcomes in Atrial Fibrillation: Randomized Comparison to Traditional Ablation
This study tests pulsed field ablation versus conventional radiofrequency ablation in adults with atrial fibrillation to see which method better preserves heart rhythm.
-
Low-intensity ultrasound to calm the nerves and improve sleep after heart surgery
This trial tests whether gentle, focused ultrasound on the left stellate ganglion can improve autonomic function and sleep after heart-related surgery in adults with cardiovascular disease, compared with a sham treatment.
-
Sex-based differences in AF wiring and how they affect outcomes
This study tests whether women have more unmapped extra-pulmonary AF triggers than men during a first-time AF ablation.
-
Genetic testing for AF-triggered cardiomyopathy
We will test whether people who develop heart failure during atrial fibrillation carry specific disease-causing gene variants compared with people who have AF but do not weaken their heart.
-
Comparison of Optrell and Octaray Mapping Catheters for Atrial Ablation
This study tests whether the Optrell catheter with V8 software can confirm conduction block during atrial ablation and compares voltage readings with Octaray in adults with atrial fibrillation.
-
Left Atrial Appendage Occlusion and Rhythm Restoration in AF Patients
This trial tests a combined procedure using the Volt PFA System and Amulet 2 to see if it safely and feasibly treats atrial fibrillation while also closing the left atrial appendage in adults with AF.
-
Remote ECG monitoring after TAVI
This compares continuous 30-day remote ECG monitoring to standard short-term monitoring for adults after TAVI to see if it detects rhythm problems earlier.
-
Early return of atrial fibrillation after pulsed field ablation and long‑term risk
We will see if early return of AF after pulsed field ablation predicts later recurrence in adults having their first ablation.
-
Somatic health screening for adults in psychiatric outpatient care
This program tries adding regular physical-health screening into psychiatric outpatient care to see if it helps detect and manage heart disease, lung disease, diabetes, and other conditions in adults with psychotic or affective disorders.
-
AccuSafe guidewire vs traditional transseptal needle for X-ray-free transseptal puncture during AF ablation
This tests whether the AccuSafe transseptal guidewire is safer and more effective than the traditional transseptal needle for people with atrial fibrillation undergoing catheter ablation guided by intracardiac echocardiography without X-rays.
-
Empagliflozin to improve left atrial function in people with paroxysmal atrial fibrillation, hypertension, and abnormal glucose metabolism
This trial tests whether taking empagliflozin once daily for 12 months can improve left atrial function in adults with paroxysmal atrial fibrillation, hypertension, and diabetes or prediabetes.
-
Understanding why AF happens and is harder to treat in hypertrophic cardiomyopathy
We’re testing how heart electrical signals and advanced imaging relate to atrial fibrillation in people with hypertrophic cardiomyopathy to see if treatments can be improved.
-
Early rhythm control treatment for subclinical atrial fibrillation
This study tests whether starting rhythm-control treatments early can reduce abnormal heart rhythm episodes in people whose subclinical atrial fibrillation was found by implantable heart devices.
-
Start CPAP After AF Ablation in OSA Patients
This study tests whether adding CPAP after AF ablation helps prevent atrial arrhythmia recurrence in adults with obstructive sleep apnea.
-
TH-75 blood pressure monitor for detecting atrial fibrillation
We will test whether the TH-75 blood pressure monitor can detect atrial fibrillation in adults with or without a prior AF diagnosis.
-
Catheter ablation plus LAAC vs anticoagulation in frail elderly A-fib patients
This study tests whether adding left atrial appendage closure to ablation is as good as using long-term blood thinners in frail people aged 75 and up with atrial fibrillation.
-
Left atrial and appendage function after pulsed-field pulmonary vein isolation in paroxysmal AF
We will test whether pulsed-field pulmonary vein isolation causes immediate changes in left atrial and left atrial appendage function in adults with paroxysmal atrial fibrillation.
-
New ways to estimate left heart pressures in people with heart failure and atrial fibrillation
This study tests a new approach that combines ultrasound and clinical data to see if doctors can better tell when the heart’s filling pressure is high in patients who have both heart failure and atrial fibrillation.
-
Long-term atrial fibrillation risk after an acute illness
A small implantable heart monitor will be used to see if adults who develop acute atrial fibrillation—especially after cardiac surgery—have more long-term recurrences than those with AF after non-cardiac surgery or medical illness.
-
Preventing stroke and systemic embolism in adults with atrial fibrillation who can't use oral blood thinners
This trial tests two experimental drugs, REGN7508 and REGN9933, to see if they reduce ischemic stroke or systemic embolism in adults with atrial fibrillation who cannot or choose not to take oral blood thinners.
-
Personalized exercise and diet program to reduce atrial fibrillation episodes and heart/body fat
This 12-month program will try personalized exercise plus dietary counseling to reduce atrial fibrillation episodes, symptoms, and heart and body fat in overweight adults with paroxysmal or persistent AF.
-
Catheter ablation vs optimized medical care for very elderly with atrial fibrillation
In people aged 78 and up with AF, this study tests whether catheter ablation can help by comparing it to tailored medical therapy, using a wearable rhythm monitor to track AF over time.
-
Extended ablation added to PVI for persistent atrial fibrillation
In adults with symptomatic persistent AF who are undergoing a first ablation, the study tests whether adding predefined linear ablation lines to pulmonary vein isolation improves freedom from AF/AT/AFL over 12 months.
-
Post-stroke heart rhythm monitoring with a wearable chest patch in Southern Norway
This test tries a small wireless chest patch worn up to 14 days to see if it finds atrial fibrillation better than the usual short hospital monitoring in people who recently had an ischemic stroke or TIA.
-
Flecainide safety in people with atrial fibrillation and stable coronary artery disease
This study tests whether flecainide is as safe as standard rhythm-control drugs for adults with atrial fibrillation and stable coronary artery disease.
-
Ablation to improve wellbeing and survival in people aged 80 and older with atrial fibrillation
This will see if catheter ablation, compared with a sham procedure, improves quality of life over six months for people aged 80 and older with symptomatic atrial fibrillation.
-
Ablation guided by hierarchical heart electrical patterns to treat atrial fibrillation
This project will try a targeted ablation guided by models of the heart's electrical organization to see if it reduces arrhythmias in adults with persistent atrial fibrillation or with recurrent ventricular arrhythmias not controlled by medicines.
-
Reprocessed versus new ablation catheters for pulmonary vein isolation
This will test whether re-sterilized (reprocessed) ablation catheters work as well and are as safe as new catheters for adults having pulmonary vein isolation for atrial fibrillation.
-
Electroporation for early AF treatment in people with HFpEF
This study will test whether electroporation pulmonary vein isolation using the FARAPULSE system works better than usual medical treatment for people with symptomatic paroxysmal atrial fibrillation who also have HFpEF.
-
Safety of perioperative blood thinner management in people with cancer undergoing surgery or procedures
This study tests how safe current practices are for stopping or continuing blood thinners in adults with cancer who are having surgery or procedures, to see if bleeding or clots are affected.
-
Silent brain lesion monitoring after VARIPULSE pulsed field ablation for atrial fibrillation
We will see if pulsed field ablation with the VARIPULSE system leads to silent brain lesions on MRI in adults treated for paroxysmal or persistent atrial fibrillation.
-
Left atrial appendage closure with AtriLASH Seralene suture during cardiac surgery for atrial fibrillation
This trial tests whether closing the left atrial appendage with the AtriLASH Seralene hemostatic suture during cardiac surgery can reduce stroke risk in adults with atrial fibrillation.
-
Using noninvasive mapping to guide atrial fibrillation ablation
This will test whether using noninvasive heart mapping to choose personalized ablation targets helps people with persistent atrial fibrillation and enlarged left atria by increasing immediate AF termination and reducing later recurrences.
-
ICE-guided cavotricuspid isthmus ablation with a circular pulsed-field catheter
This will see if a circular-shaped pulsed field ablation catheter, guided by intracardiac echocardiography, can safely and effectively achieve acute cavotricuspid isthmus ablation in adults with atrial fibrillation.
-
Concomitant Pulsed Field Ablation and Left Atrial Appendage Closure in AF Patients
In patients with atrial fibrillation who need both ablation and left atrial appendage closure, this study tests doing both procedures in a single intervention using FARAPULSE PFA and a WATCHMAN FLX device.
-
Atrial fibrillation screening for people with higher-than-median NT-proBNP in Tromsø
This will test whether giving 7-day wearable ECG monitoring to people aged 40+ with NT-proBNP above the median can find atrial fibrillation and reduce ischemic stroke and vascular deaths compared with no long-term monitoring.
-
Progressive Resistance Training First to Help AF and HFpEF Patients Feel Better
This trial tests whether starting with progressive resistance training before aerobic exercise can improve exercise capacity and quality of life in people aged 60 and older who have atrial fibrillation and HFpEF.
-
Digital MediYoga for quality of life and heart measures in paroxysmal atrial fibrillation
This trial will test whether a 12-week, app-delivered MediYoga program can improve disease-specific quality of life and reduce blood pressure and heart rate in adults with paroxysmal atrial fibrillation.
-
Personalized AF ablation guided by non-invasive global mapping
This project will test whether using a non-invasive global mapping system to guide personalized additional ablation after standard pulmonary vein isolation helps people with persistent atrial fibrillation and enlarged left atria have fewer recurrences.
-
Redo AF ablation using the Sphere-9 catheter and Affera system for recurrent paroxysmal and persistent atrial fibrillation
The study will try the Sphere-9 catheter with the Affera ablation and mapping systems for adults who have symptomatic recurrent paroxysmal or persistent atrial fibrillation after one prior ablation.
-
Watchman Elite Left Atrial Appendage Closure Device in AF patients seeking a non-drug option
This study tests whether the Watchman Elite LAAC device can safely and effectively reduce stroke risk in people with non-valvular atrial fibrillation who want a non-pharmacologic alternative to anticoagulation.
-
Atrial fibrillation screening for people with abnormal echocardiograms
We will see if using certain abnormal echocardiogram measurements to select people for scheduled extended ECG monitoring finds more atrial fibrillation than usual care.
-
Waiting on Atrial Fibrillation Intervention Therapy: Weight loss before ablation
This trial tests whether adding weekly semaglutide before first-time AF ablation helps people who are overweight or obese have better rhythm outcomes.
-
Ablation versus medication for atrial fibrillation in people with preserved or mildly reduced heart function
This trial will randomly assign adults with atrial fibrillation and heart failure with preserved or mildly reduced ejection fraction to either catheter ablation (rhythm control) or medications for rate control to see which approach leads to better survival, fewer hospital stays, and improved quality of life.
-
Pre-ablation prehabilitation to improve recovery after atrial fibrillation ablation
A 4-week supervised program of exercise and psychological education will be tested in people with atrial fibrillation scheduled for their first catheter ablation to see if it improves post-procedure fitness and clinical outcomes compared with usual care.
-
AP31969 versus placebo to control heart rhythm in people with atrial fibrillation
This trial tests whether taking oral AP31969 twice daily at several doses can lower AF burden compared with a placebo in adults with paroxysmal or persistent atrial fibrillation.
-
Effect of pulmonary vein isolation on sleep breathing in people with paroxysmal atrial fibrillation
This study will test whether pulmonary vein isolation (a common AF ablation) changes sleep breathing measurements in people with paroxysmal atrial fibrillation who have risk factors for sleep apnea.
-
Left bundle branch pacing versus right ventricular pacing to reduce device‑detected fast atrial episodes in people with preserved ejection fraction
This trial will test whether left bundle branch pacing (LBBP) reduces the total time people with preserved ejection fraction spend in device‑detected fast atrial episodes compared with standard right ventricular pacing.
-
Disrupted sleep and irregular heartbeats in people with hypoglossal nerve stimulators
This study will test whether turning a hypoglossal nerve stimulation (HGNS) device off for a night increases the chance of irregular heartbeats or short atrial fibrillation episodes in adults with obstructive sleep apnea who already have an HGNS implant.
-
Left bundle branch area pacing with Tendril STS or UltiPace leads
This study will try left bundle branch area pacing with the Tendril STS or UltiPace lead in adults who need pacemaker leads for bradycardia or related heart conditions to see if pacing and sensing are safe and work through six months after implant.
-
Tracking outcomes after heart rhythm procedures in Düsseldorf.
This registry collects information to see how safe and effective routine electrophysiology procedures (like catheter ablation and cardioversion) are for people treated for AF, atrial flutter, supraventricular tachycardias, or VT at University Hospital Düsseldorf.
-
Dapagliflozin to prevent atrial fibrillation coming back after cardioversion
This trial tests whether taking dapagliflozin once daily can reduce the chance that atrial fibrillation returns after an electric cardioversion in adults aged 55 and older.
-
Safety of two new clot-preventing medicines for adults with atrial fibrillation on anticoagulation
This trial will test two experimental medicines, REGN7508 and REGN9933, against apixaban to see if they prevent clots with acceptable bleeding risk in adults with atrial fibrillation who need long-term anticoagulation.
-
Wearable cardiac monitoring for early arrhythmia detection and remote management
This project will try a smartwatch-based system to spot arrhythmias early and help manage adults with chronic or recently treated heart problems.
-
Using a pulsed-field balloon catheter to isolate pulmonary veins for atrial fibrillation
This trial will test whether pulsed field ablation with the VOLT balloon catheter works as well as standard thermal ablation for adults having their first pulmonary vein isolation for atrial fibrillation.
-
Village-based program to manage chronic heart conditions in Qujiang older adults
This project will try a village-based program combining medicines, lifestyle support, education, and 7-day ECG monitoring for people aged 60+ in Qujiang with chronic heart conditions such as atrial fibrillation, high blood pressure, coronary artery disease, or heart failure.
-
Electroporation versus Radiofrequency Ablation Guided by 3D Imaging for Repeat Atrial Fibrillation
This trial tests whether pulsed field electroporation or standard radiofrequency ablation works better and safer for people having a repeat catheter ablation for recurrent atrial fibrillation.
-
Comparing FARAPULSE and FARAWAVE Nav catheters during pulmonary vein isolation for atrial fibrillation
This test will see if the FARAWAVE Nav catheter's built-in mapping can be used instead of pre-procedure CT scans for adults having pulmonary vein isolation for atrial fibrillation.
-
Pulsed field ablation registry for atrial arrhythmias in Poland.
This project will collect information to see how well pulsed field ablation works and how safe it is for people in Poland having ablation for atrial fibrillation, atrial flutter, or atrial tachycardia.
-
Marshall vein ethanol injection plus pulsed-field pulmonary vein isolation for paroxysmal atrial fibrillation
This trial will test whether injecting ethanol into the vein of Marshall in addition to pulsed-field pulmonary vein isolation reduces return of atrial fibrillation in adults with symptomatic paroxysmal AF undergoing their first ablation.
-
Cardiovascular risk in people with Crohn's disease and ulcerative colitis
This study tests whether people with inflammatory bowel disease have different heart-attack or stroke risk over two years compared with matched controls.
-
Comprehensive imaging of valve regurgitation and recurrence risk after atrial fibrillation ablation
This project will use 3D transesophageal and transthoracic echocardiography to try to find imaging signs that predict valve regurgitation and which adults with atrial fibrillation planning ablation are more likely to have recurrence.
-
Daily AMBROSIA nutritional bar to prevent undernutrition and muscle loss in older adults with AF or heart failure
This trial will try a daily AMBROSIA functional food plus nutritional counseling to see if it prevents undernutrition and muscle loss in people over 70 with atrial fibrillation or heart failure.
-
Substrate remodelling and targeted ablation for persistent atrial fibrillation
This project will try using detailed 3D electrical mapping of the left atrium to guide targeted ablation (pulmonary vein reisolation, ganglionic plexi, and substrate ablation) for people with persistent atrial fibrillation undergoing their first catheter ablation.
-
Comparing two pulsed-field ablation catheters for atrial fibrillation with left atrial appendage closure
This will try two different pulsed-field ablation catheters in people with symptomatic, drug-refractory atrial fibrillation who also need left atrial appendage closure to see which is safer and more effective.
-
Catheter Ablation for Atrial Fibrillation and Ventricular Tachycardia: A Chinese Registry
This registry follows adults with atrial fibrillation or ventricular tachycardia to see how well and safely catheter ablation works over time in real-world Chinese patients.
-
Kardi Ai ECG telemetry monitoring for detecting heart rhythm problems
The Kardi Ai wearable ECG system will be tested to see if it can accurately detect irregular heart rhythms in adults with or suspected of having heart rhythm disorders.
-
Using a quick CT scan to check for left atrial clots before cardioversion in the Emergency Department
This will test whether a rapid cardiac CT in the ED to look for left atrial clots lets people with symptomatic atrial fibrillation or flutter have safe same‑day cardioversion instead of being admitted or delayed.
-
Digital interventions to manage alcohol consumption and atrial fibrillation severity
This study is testing whether using a special app and text messages to help people cut down or quit drinking alcohol can improve heart rhythm problems in those with atrial fibrillation.
-
Registry of adult patients with atrial fibrillation in China
This study is creating a long-term registry of adults with atrial fibrillation in China to see how different treatments work and how they affect patients' lives.
-
Cycle-length mapping with OPTRELL for non-paroxysmal atrial fibrillation
This will try an ultra-high-density OPTRELL mapping catheter to map electrical cycle length and voltage in people with persistent or permanent atrial fibrillation to better target ablation.
-
Managing anticoagulants for patients needing high-risk surgery
This study is testing a new way to manage blood-thinning medications for patients who need high-risk surgeries to see if it keeps them safer than the current method.
-
Music during catheter ablation for atrial fibrillation under light sedation
This test will see if playing music during catheter ablation helps adults having their first atrial fibrillation procedure feel less anxious and in less pain while using light sedation.
-
Understanding heart injury in patients with rapid atrial fibrillation
This study is trying to see if people with rapid atrial fibrillation and heart injury are more likely to have blocked arteries compared to those without heart injury, using blood tests and heart imaging.
-
Assessing stroke risk in patients with newly diagnosed atrial fibrillation
This study is testing how to identify stroke risk in people who have just been diagnosed with atrial fibrillation to see who might need blood-thinning medication to prevent strokes.
-
AI-guided ECG mapping plus pulmonary vein isolation for atrial fibrillation
This trial tests whether adding the vMap® AI 12-lead ECG mapping system to standard pulmonary vein isolation helps adults with persistent or recurrent atrial fibrillation have better outcomes.
-
Catheter ablation for people with persistent atrial fibrillation and severe atrial functional mitral regurgitation
This will test whether adding catheter ablation to usual medicines helps adults with persistent atrial fibrillation and moderate-to-severe or severe atrial functional mitral regurgitation reduce valve leakage and improve symptoms and outcomes.
-
Stopping anticoagulants after successful atrial fibrillation ablation with intensive smartwatch monitoring
This trial will test whether adults 18–80 who are 60–365 days after a successful AF ablation and have been on a NOAC can safely stop their blood thinner while using frequent smartwatch and patch monitoring, aiming to lower bleeding without raising stroke or embolism risk.
-
Combining pulmonary vein isolation and left atrial appendage closure for atrial fibrillation treatment
This study is testing if combining two procedures—one to isolate the pulmonary veins and another to close off a part of the heart—can help people with non-valvular atrial fibrillation who can't take blood thinners and are at high risk for stroke.
-
AI-ECG alerts to catch early atrial fibrillation risk
This trial tests whether an AI-powered ECG alert can help doctors find people at high risk of developing atrial fibrillation so they can be given continuous heart-rhythm monitoring.
-
Virtual management of anticoagulant therapy for patients needing elective surgery
This study is testing if virtual visits can safely manage blood thinner therapy for patients with atrial fibrillation who need elective surgery, instead of having them come in for in-person appointments.
-
AI-driven 7-day single-lead ECG patch monitoring to detect new atrial fibrillation in older adults
This project will test whether AI-read 7-day single-lead ECG patches can find new atrial fibrillation in people aged 60 and older in rural China better than routine 12-lead ECG screening.
-
Exercise program for patients after atrial fibrillation ablation
This study is testing whether a structured exercise program can help people who had atrial fibrillation ablation feel better and improve their heart health and quality of life.
-
Understanding Ischemic Stroke in Patients Taking Blood Thinners
This study looks at how ischemic strokes affect people taking blood thinners for heart issues to see what helps prevent future strokes.
-
Pulsed-field ablation of the posterior left atrium and mitral isthmus for non-paroxysmal AF
This tests the Varipulse pulsed-field ablation catheter for isolating pulmonary veins and treating the left atrial posterior wall and mitral isthmus in people with non-paroxysmal atrial fibrillation.
-
Reliability of Two-Stage Multiple-Repetition-Maximum Tests to Estimate 1-RM in People with Heart Disease and Risk Factors
This study checks how well different formulas estimate the 1-RM from two submaximal tests in adults with heart disease or risk factors.
-
Coherent Sine-Burst Electroporation (CSE) Ablation for Atrial Fibrillation
This study will test whether the Argá Medtech CSE electroporation device can safely and effectively ablate heart tissue to treat adults with symptomatic paroxysmal or persistent atrial fibrillation who have not responded to drugs.
-
Integrated care for older patients with atrial fibrillation
This study is testing a new team-based care approach for older patients with atrial fibrillation and other health issues to see if it helps them manage their condition better than regular care.
-
Effects of Alcohol Consumption on Atrial Fibrillation Episodes
This study is testing whether drinking small to moderate amounts of alcohol affects how often people with paroxysmal atrial fibrillation have episodes of irregular heartbeats.
-
Identifying metabolic markers for preventing atrial fibrillation
This study is trying to find specific metabolic markers in patients having heart surgery to see if they can help predict and prevent the return of atrial fibrillation.
-
Preventing POAF after heart surgery with posterior pericardiotomy
This trial tests whether posterior pericardiotomy during cardiac surgery can reduce new atrial fibrillation after surgery in adults in China.
-
Biodegradable amiodarone patches placed on the heart to prevent atrial fibrillation after open-heart surgery
This trial will try placing biodegradable patches soaked with amiodarone on the outside of the atria during open-heart surgery to see if it reduces new atrial fibrillation after elective cardiac operations.
-
Pacing and Ablation for Patients with Atrial Fibrillation
This study is testing whether a combination of a special pacemaker and a procedure to block heart signals can help people with tough-to-treat atrial fibrillation feel better compared to just using medications.
-
Early versus later restart of blood thinners after surgery for chronic subdural hematoma in people with atrial fibrillation
This trial will test whether restarting oral blood thinners 5 days versus 30 days after surgery is safer and better at preventing clots for adults with atrial fibrillation who had surgery for chronic subdural hematoma.
-
Screening for Atrial Fibrillation after Stroke
This study tests if checking for heart rhythm problems right after a stroke helps find more cases of atrial fibrillation compared to checking after leaving the hospital, and it also compares two different devices used for this screening.
-
Pulsed field versus radiofrequency approaches to change vagal nerve effects during pulmonary vein isolation for paroxysmal AF
This study tests whether pulsed field ablation, alone or combined with radiofrequency, changes vagal nerve activity during pulmonary vein isolation in people with paroxysmal atrial fibrillation.
-
Home testing for sleep apnea to improve well-being in patients with atrial fibrillation
This study is testing if home testing and treatment for sleep apnea can help people with atrial fibrillation feel better and improve their quality of life.
-
Discontinuing blood thinners after successful catheter ablation for atrial fibrillation
This study tests whether stopping anticoagulation after a successful AF ablation is safe for patients who have had no recurrence within a year.
-
Comparing catheter ablation (cryo, radiofrequency, pulsed field) with medical therapy for people with atrial fibrillation and heart failure.
This study will see if catheter ablation plus optimal heart-failure medicines helps people with atrial fibrillation and heart failure have fewer unplanned heart-failure hospital stays and lower risk of death than medicines alone.
-
HeartWatch vs Holter: A Longer-Term Arm Monitors Heart Rhythm
This study tests whether the HeartWatch arm monitor can match or improve on Holter monitoring for detecting rhythm problems in adults with suspected AF and other arrhythmias.
-
Using focal pulse ablation to treat atrial flutter and fibrillation
This study is testing a new treatment using focal pulse ablation to see if it can help people with atrial flutter feel better and reduce their symptoms.
-
Using P2Y12 inhibitors alone for patients with atrial fibrillation getting stents
This study is testing if using just one type of blood thinner for a month, followed by a different one, is safer and just as effective for people with atrial fibrillation who are getting heart stents, compared to the usual combination of three blood thinners.
-
Evaluating abelacimab for patients with atrial fibrillation unsuitable for oral anticoagulation
This study is testing a new medication called abelacimab to see if it can help people with atrial fibrillation who can't take blood thinners avoid strokes.
-
Comparing LAA closure and anticoagulation for atrial fibrillation patients after brain bleeding
This study is testing whether closing a part of the heart or using blood thinners is better for preventing strokes in patients with atrial fibrillation who have had a brain bleed.
-
Registry for patients with coronary artery disease and atrial fibrillation
This study collects information from patients with coronary artery disease and atrial fibrillation to see how local care can improve their symptoms and quality of life.
Related topics
Quick answers
How many Atrial Fibrillation (AF) clinical trials are recruiting right now?
137, as of November 12, 2026. 3 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 54 countries. The most sites are in China (30 trials), United States (24 trials), Germany (14 trials), Poland (13 trials), Spain (13 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 6, Phase 2: 5, Phase 4: 4, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.